Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ALUR NASDAQ:NTRB NASDAQ:STRR NASDAQ:TELA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALURAllurion Technologies$0.87$0.79$0.23▼$3.33$13.06M-0.131.56 million shs26,379 shsNTRBNutriband$3.58$3.76$3.21▼$11.68$43.53M1.99,538 shs3,921 shsSTRRStar Equity$11.30$10.15$8.26▼$11.99$41.81M0.497,884 shs12,595 shsTELATELA Bio$0.88$0.79$0.50▼$2.20$39.40M1.33112,619 shs66,348 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALURAllurion Technologies0.00%+22.65%+11.66%+81.42%-67.75%NTRBNutriband0.00%+0.11%-4.53%-15.76%-53.51%STRRStar Equity0.00%-2.75%+19.45%+13.36%+430.52%TELATELA Bio0.00%-9.27%-13.72%-0.56%-53.43%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALURAllurion Technologies$0.87$0.79$0.23▼$3.33$13.06M-0.131.56 million shs26,379 shsNTRBNutriband$3.58$3.76$3.21▼$11.68$43.53M1.99,538 shs3,921 shsSTRRStar Equity$11.30$10.15$8.26▼$11.99$41.81M0.497,884 shs12,595 shsTELATELA Bio$0.88$0.79$0.50▼$2.20$39.40M1.33112,619 shs66,348 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALURAllurion Technologies0.00%+22.65%+11.66%+81.42%-67.75%NTRBNutriband0.00%+0.11%-4.53%-15.76%-53.51%STRRStar Equity0.00%-2.75%+19.45%+13.36%+430.52%TELATELA Bio0.00%-9.27%-13.72%-0.56%-53.43%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALURAllurion Technologies 2.00Hold$3.00244.51% UpsideNTRBNutriband 1.50ReduceN/AN/ASTRRStar Equity 2.20Hold$28.00147.79% UpsideTELATELA Bio 2.40Hold$2.20149.97% UpsideCurrent Analyst Ratings BreakdownLatest ALUR, STRR, NTRB, and TELA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/3/2026NTRBNutriband Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)5/20/2026STRRStar Equity Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/20/2026STRRStar Equity Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell5/8/2026NTRBNutriband Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)5/6/2026STRRStar Equity Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)4/21/2026TELATELA Bio Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)3/27/2026TELATELA Bio Citizens JmpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetMarket Outperform$5.00 ➝ $3.003/25/2026TELATELA Bio Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$1.25 ➝ $1.003/25/2026TELATELA Bio Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$3.00 ➝ $2.003/25/2026TELATELA Bio Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$4.00 ➝ $2.003/23/2026STRRStar Equity Litchfield Hills ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$21.00 ➝ $28.00(Data available from 6/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALURAllurion Technologies$17.21M0.76N/AN/A($30.08) per share-0.03NTRBNutriband$2.04M21.34N/AN/A$0.55 per share6.51STRRStar Equity$172.16M0.24$0.63 per share17.83$19.12 per share0.59TELATELA Bio$80.28M0.49N/AN/A$0.16 per share5.50Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALURAllurion Technologies-$7.20M-$2.03N/AN/AN/A-199.96%N/A-77.13%8/18/2026 (Estimated)NTRBNutriband-$8.23M-$2.60N/AN/AN/A-403.98%-118.33%-101.92%N/ASTRRStar Equity-$5.92M-$2.63N/A10.87N/A-4.18%-4.04%-2.40%8/6/2026 (Estimated)TELATELA Bio-$38.83M-$0.79N/AN/AN/A-49.30%-1,320.81%-55.83%8/10/2026 (Estimated)Latest ALUR, STRR, NTRB, and TELA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/12/2026Q1 2026TELATELA Bio-$0.14-$0.21-$0.07-$0.21$18.60 million$19.06 million5/11/2026Q1 2026STRRStar Equity$0.05-$0.99-$1.04-$1.17$52.57 million$50.06 million3/24/2026Q4 2025TELATELA Bio-$0.18-$0.16+$0.02-$0.17$21.04 million$20.87 million3/17/2026Q4 2025STRRStar Equity$0.13-$0.10-$0.23-$0.67$59.08 million$56.79 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthALURAllurion TechnologiesN/AN/AN/AN/AN/ANTRBNutribandN/AN/AN/AN/AN/ASTRRStar EquityN/AN/AN/AN/AN/ATELATELA BioN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioALURAllurion TechnologiesN/A1.260.94NTRBNutriband0.016.366.21STRRStar Equity0.092.091.84TELATELA Bio8.823.612.92Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipALURAllurion Technologies21.39%NTRBNutriband19.70%STRRStar Equity3.84%TELATELA Bio94.35%Insider OwnershipCompanyInsider OwnershipALURAllurion Technologies8.10%NTRBNutriband52.21%STRRStar Equity10.40%TELATELA Bio4.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableALURAllurion Technologies50114.99 million11.28 millionNo DataNTRBNutriband1012.16 million5.81 millionNot OptionableSTRRStar Equity1,2003.70 million3.31 millionNot OptionableTELATELA Bio12044.77 million42.66 millionOptionableALUR, STRR, NTRB, and TELA HeadlinesRecent News About These CompaniesTELA Bio Healthcare Story Faces New Market ScrutinyMay 15, 2026 | kalkinemedia.comKEarnings Release: Here's Why Analysts Cut Their TELA Bio, Inc. (NASDAQ:TELA) Price Target To US$2.25May 15, 2026 | finance.yahoo.comTELA Bio Inc (TELA) Q1 2026 Earnings Call Highlights: Strong European Growth and Strategic U.S. ...May 13, 2026 | finance.yahoo.comTELA Bio, Inc. (TELA) Q1 2026 Earnings Call TranscriptMay 12, 2026 | seekingalpha.comTELA Bio, Inc. (TELA) Reports Q1 Loss, Beats Revenue EstimatesMay 12, 2026 | zacks.comTELA Bio Reports First Quarter 2026 Financial ResultsMay 12, 2026 | globenewswire.comWhat To Expect From TELA Bio Inc (TELA) Q1 2026 EarningsMay 11, 2026 | finance.yahoo.comTELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 7, 2026 | globenewswire.comAxos, Gallagher and TELA Bio post strong growth and strategic movesMay 1, 2026 | msn.comTELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports ...April 30, 2026 | markets.businessinsider.comTELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 RevenuesApril 30, 2026 | globenewswire.comTELA Bio (TELA) Gets a Buy from Canaccord GenuityApril 26, 2026 | theglobeandmail.comTELA Bio to Announce First Quarter 2026 Financial ResultsApril 21, 2026 | globenewswire.comTELA Bio (TELA) price target decreased by 34.78% to 2.30April 10, 2026 | msn.comTELA Bio, Inc. Q4 2025 Earnings Call SummaryMarch 26, 2026 | finance.yahoo.comTELA Bio, Inc.: TELA Bio Reports Fourth Quarter and Full Year 2025 Financial ResultsMarch 26, 2026 | finanznachrichten.deTELA Bio (TELA) Q4 2025 Earnings Call TranscriptMarch 26, 2026 | finance.yahoo.comTELA Bio Q4 Earnings Call HighlightsMarch 26, 2026 | defenseworld.netDTELA Bio Analysts Cut Their Forecasts After Q4 ResultsMarch 25, 2026 | benzinga.comTELA Bio, Inc. (NASDAQ:TELA) Q4 2025 Earnings Call TranscriptMarch 25, 2026 | insidermonkey.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeALUR, STRR, NTRB, and TELA Company DescriptionsAllurion Technologies NYSE:ALUR$0.87 0.00 (0.00%) As of 06/5/2026 03:58 PM EasternAllurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.Nutriband NASDAQ:NTRB$3.58 0.00 (0.00%) Closing price 06/5/2026 03:49 PM EasternExtended Trading$3.48 -0.11 (-2.93%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida.Star Equity NASDAQ:STRR$11.30 0.00 (0.00%) Closing price 06/5/2026 03:55 PM EasternExtended Trading$11.16 -0.14 (-1.24%) As of 03:59 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Star Equity Holdings, Inc. engages in the construction business in the United States and internationally. It operates through two segments: Construction, and Investments. It manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; holds real estate assets; and manages investments. The company was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Old Greenwich, Connecticut.TELA Bio NASDAQ:TELA$0.88 0.00 (0.00%) Closing price 06/5/2026 04:00 PM EasternExtended Trading$0.88 0.00 (-0.01%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/01 - 06/05 Samsara Just Answered The AI Question—Is Wall Street Ready To Listen? A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below Five Below Down 12% Post Earnings—Is the Selloff Overdone? Petco Faces Tough Competition, But Momentum Is Building IREN's 800MW Bet Flips the AI Power Switch Buy the Dip? Broadcom's AI Moat Is Wider Than Ever CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
